Palliative care in advanced cancer patients: how and when?
E Bruera, S Yennurajalingam - The oncologist, 2012 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the impact of early access to palliative care service on symptom control, quality of life, and …
the impact of early access to palliative care service on symptom control, quality of life, and …
Randomized trial of a palliative care intervention to improve end-of-life care discussions in patients with metastatic breast cancer
JA Greer, B Moy, A El-Jawahri, VA Jackson… - Journal of the National …, 2022 - jnccn.org
Background: Studies show that early, integrated palliative care (PC) improves quality of life
(QoL) and end-of-life (EoL) care for patients with poor-prognosis cancers. However, the …
(QoL) and end-of-life (EoL) care for patients with poor-prognosis cancers. However, the …
Clinician roles in early integrated palliative care for patients with advanced cancer: a qualitative study
Background: Early palliative care provides better quality of life, increased prognostic
awareness, and even improved survival for patients with advanced cancer but how the …
awareness, and even improved survival for patients with advanced cancer but how the …
Development and validation of a novel nomogram for individualized prediction of survival in cancer of unknown primary
K Raghav, H Hwang, AA Jácome, E Bhang… - Clinical Cancer …, 2021 - AACR
Purpose: Prognostic uncertainty is a major challenge for cancer of unknown primary (CUP).
Current models limit a meaningful patient-provider dialogue. We aimed to establish a …
Current models limit a meaningful patient-provider dialogue. We aimed to establish a …
[HTML][HTML] Current state of the art and science of patient-clinician communication in progressive disease: patients' need to know and need to feel known
LM van Vliet, AS Epstein - Journal of Clinical Oncology, 2014 - ncbi.nlm.nih.gov
Effective communication rests at the core of medicine, especially when patients are
confronted with progressive disease and death. Communication can mitigate the distress of …
confronted with progressive disease and death. Communication can mitigate the distress of …
Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer
AB Chen, A Cronin, JC Weeks… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Although radiation therapy (RT) can palliate symptoms and may prolong life, it is
not curative for patients with metastatic lung cancer. We investigated patient expectations …
not curative for patients with metastatic lung cancer. We investigated patient expectations …
Early integration of palliative care facilitates the discontinuation of anticancer treatment in women with advanced breast or gynecologic cancers
Objectives To evaluate some health indicators in women with advanced breast or
gynecological cancers (ABGCs) after discontinuation of active cancer treatment in function of …
gynecological cancers (ABGCs) after discontinuation of active cancer treatment in function of …
[HTML][HTML] Palliative radiation therapy for oncologic emergencies in the setting of COVID-19: approaches to balancing risks and benefits
Palliation of metastatic disease compromises a significant portion of radiation treatments in
the United States. These patients present a unique challenge in resource-limited settings, as …
the United States. These patients present a unique challenge in resource-limited settings, as …
Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer.
Objective: Of all cancers, advanced nonsmall cell lung cancer (NSCLC) is associated with
the highest burden on mental and physical health-related quality of life (HRQoL). Patients' …
the highest burden on mental and physical health-related quality of life (HRQoL). Patients' …
Patient‐clinician discordance in perceptions of treatment risks and benefits in older patients with acute myeloid leukemia
A El‐Jawahri, M Nelson‐Lowe, H VanDusen… - The …, 2019 - academic.oup.com
Background Older patients (≥ 60 years) with acute myeloid leukemia (AML) face difficult
decisions regarding treatment with “intensive” chemotherapy that carries significant toxicity …
decisions regarding treatment with “intensive” chemotherapy that carries significant toxicity …